1. Home
  2. NAMS vs CARG Comparison

NAMS vs CARG Comparison

Compare NAMS & CARG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • CARG
  • Stock Information
  • Founded
  • NAMS 2019
  • CARG 2005
  • Country
  • NAMS Netherlands
  • CARG United States
  • Employees
  • NAMS N/A
  • CARG N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • CARG EDP Services
  • Sector
  • NAMS Health Care
  • CARG Technology
  • Exchange
  • NAMS Nasdaq
  • CARG Nasdaq
  • Market Cap
  • NAMS 3.1B
  • CARG 3.2B
  • IPO Year
  • NAMS N/A
  • CARG 2017
  • Fundamental
  • Price
  • NAMS $38.74
  • CARG $34.39
  • Analyst Decision
  • NAMS Strong Buy
  • CARG Buy
  • Analyst Count
  • NAMS 10
  • CARG 12
  • Target Price
  • NAMS $43.70
  • CARG $39.54
  • AVG Volume (30 Days)
  • NAMS 1.3M
  • CARG 862.5K
  • Earning Date
  • NAMS 11-06-2025
  • CARG 11-06-2025
  • Dividend Yield
  • NAMS N/A
  • CARG N/A
  • EPS Growth
  • NAMS N/A
  • CARG N/A
  • EPS
  • NAMS N/A
  • CARG 1.24
  • Revenue
  • NAMS $64,006,000.00
  • CARG $919,087,000.00
  • Revenue This Year
  • NAMS N/A
  • CARG $6.30
  • Revenue Next Year
  • NAMS N/A
  • CARG $5.82
  • P/E Ratio
  • NAMS N/A
  • CARG $27.53
  • Revenue Growth
  • NAMS 762.15
  • CARG 4.79
  • 52 Week Low
  • NAMS $14.06
  • CARG $24.65
  • 52 Week High
  • NAMS $41.47
  • CARG $41.33
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 66.43
  • CARG 41.74
  • Support Level
  • NAMS $35.50
  • CARG $33.87
  • Resistance Level
  • NAMS $39.03
  • CARG $36.99
  • Average True Range (ATR)
  • NAMS 2.30
  • CARG 0.92
  • MACD
  • NAMS -0.16
  • CARG -0.16
  • Stochastic Oscillator
  • NAMS 61.67
  • CARG 32.61

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About CARG CarGurus Inc.

CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.

Share on Social Networks: